Parvinder K Aley Selected Research

ChAdOx1 nCoV-19

11/2022	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
12/2021	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
1/2021	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
1/2021	Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
1/2021	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
1/2020	Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Parvinder K Aley Research Topics

Disease

11	COVID-19 11/2022 - 01/2020
4	Pain (Aches) 11/2022 - 01/2020
4	Fever (Fevers) 11/2022 - 01/2021
4	Hypoxia (Hypoxemia) 03/2010 - 04/2005
3	Infections 11/2021 - 01/2021
2	Headache (Headaches) 12/2021 - 01/2020
2	Cough 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
1	Meningococcal Infections 12/2022
1	Fatigue 01/2022
1	Asymptomatic Infections 11/2021
1	HIV Infections (HIV Infection) 01/2021
1	Chills 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2013
1	Neointima 11/2008

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 01/2021
8	ChAdOx1 nCoV-19IBA 11/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2010
3	MenACWYIBA 12/2022 - 01/2020
3	Nucleic AcidsIBA 10/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
1	serogroup C meningococcal conjugate vaccineIBA 12/2022
1	Conjugate VaccinesIBA 12/2022
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	AntibodiesIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	P-2 (P 2)IBA 10/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2013
1	LithiumIBA 01/2013
1	ebselenIBA 01/2013
1	SolutionsIBA 03/2010
1	Blood Proteins (Serum Proteins)IBA 03/2010
1	CopperIBA 03/2010
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 03/2010
1	Cyclic ADP-Ribose (cADPR)IBA 01/2006
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2006
1	RyanodineIBA 04/2005
1	Adenosine Triphosphate (ATP)IBA 04/2005
1	AntioxidantsIBA 04/2005
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2005
1	Inositol (Myoinositol)IBA 04/2005
1	Fura-2 (Fura 2)IBA 04/2005

Therapy/Procedure

1	Intramuscular Injections 01/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2008
1	Operative Surgical Procedures 11/2008